Response to letter to the editor and comment concerning “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”

June 14, 2021

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren’t any new results

Optional text in email:

Additional articles :

Predictive factors for residual leg numbness after decompression surgery for lumbar degenerative dis...

Correction to: Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar ...

Anatomic Gradients in the Microbiology of Spinal Fusion Surgical Site Infection and Resistance to Su...

Enhanced Recovery Components for Posterior Lumbar Spine Fusion: Harnessing National Data to Compare ...

Lateral-anterior lumbar interbody fusion (LaLIF) for lumbar degenerative disease: Technical notes, s...

undefined